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In South Korea, the number of Q fever cases has rapidly increased since 2015. Therefore,
this study aimed to characterize the epidemiological and clinical features of Q fever in South
Korea between 2011 and 2017.
Methods/Principal findings
We analyzed the epidemiological investigations and reviewed the medical records from all
hospitals that had reported at least one case of Q fever from 2011 to 2017. We also con-
ducted an online survey to investigate physicians’ awareness regarding how to appropri-
ately diagnose and manage Q fever. The nationwide incidence rate of Q fever was annually
0.07 cases per 100,000 persons. However, there has been a sharp increase in its incidence,
reaching up to 0.19 cases per 100,000 persons in 2017. Q fever sporadically occurred
across the country, with the highest incidences in Chungbuk (0.53 cases per 100,000 per-
sons per year) and Chungnam (0.27 cases per 100,000 persons per year) areas. Patients
with acute Q fever primarily presented with mild illnesses such as hepatitis (64.5%) and iso-
lated febrile illness (24.0%), whereas those with chronic Q fever were likely to undergo sur-
gery (41.2%) and had a high mortality rate (23.5%). Follow-up for 6 months after acute Q
fever was performed by 24.0% of the physician respondents, and only 22.3% of them
reported that clinical and serological evaluations were required after acute Q fever
diagnosis.
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Conclusions
Q fever is becoming an endemic disease in the midwestern area of South Korea. Given the
clinical severity and mortality of chronic Q fever, physicians should be made aware of appro-
priate diagnosis and management strategies for Q fever.
Author summary
Human Q fever, zoonosis caused by Coxiella burnetii, presents with diverse clinical mani-
festations, from self-limited febrile illnesses to endocarditis. It is usually diagnosed using
serological tests. Because of the diagnostic challenge and nonspecific symptoms, it has
been considered an underrecognized infectious disease, particularly in non-endemic or
non-epidemic areas. In South Korea, Q fever was designated as a notifiable disease in
2006, and the number of Q fever cases has increased sharply since 2015. This study shows
that Q fever is becoming an endemic disease in the midwestern area of South Korea. In
this study, patients with acute Q fever primarily presented with mild illnesses such as hep-
atitis (64.5%) and isolated febrile illness (24.0%). However, patients with chronic Q fever
presented with vascular infection (52.9%) and endocarditis (35.3%); such patients were
likely to undergo surgery (41.2%) and had a high mortality rate (23.5%). We also surveyed
physicians’ awareness regarding how to appropriately diagnose and manage Q fever. This
survey showed that more than half of the physicians did not follow-up suspected patients
with acute Q fever who had negative serological results at the early stage of illness using a
serological test and that follow-ups for identifying chronic Q fever after primary C. burne-
tii infection were only performed by 24.0% of physicians.
Introduction
Human Q fever is a worldwide zoonosis caused by Coxiella burnetii. It presents with diverse
clinical manifestations, from self-limited febrile illnesses to endocarditis. Although transmis-
sion to humans can occur through direct contact with infected animals, the primary route of
transmission is inhalation of the organism through aerosol particles from a contaminated
environment [1]. Therefore, Q fever can occur in community-living individuals who are not
exposed to well-known risk factors, such as contact with animals or occupational exposures,
and has resulted in large-scale outbreaks [2].
Q fever is usually diagnosed using serological tests in patients with relevant symptoms of C.
burnetii infection. Indirect immunofluorescence antibody (IFA) tests, in which the paired
serum samples are obtained 3–6 weeks apart, are used to confirm the diagnosis [3]. Thus, Q
fever has long been considered an underdiagnosed and underreported disease [4,5]. Although
acute Q fever is usually benign with a low mortality rate, a large-scale outbreak of Q fever can
lead to public health concerns such as blood transfusion-related transmission or obstetrical
complications in pregnant women. Furthermore, chronic Q fever has been observed as a per-
sistent localized infection in<5% of patients with C. burnetii infections. Chronic Q fever is
often difficult to treat, and it can be fatal in 5%–50% of patients, if left untreated [3,6].
In South Korea, Q fever was designated as a mandatory notifiable infectious disease in
2006. Between 2006 and 2011, the number of annual cases of Q fever reported to the Korean
Centers for Disease Control and Prevention (KCDC) was approximately 10 [7]. Since 2015,
the number of reported cases has increased rapidly. However, there are limited data regarding
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the recent epidemiological and clinical characteristics of patients infected with C. burnetii in
South Korea. Therefore, this study aimed to characterize the epidemiological and clinical fea-
tures of Q fever in South Korea between 2011 and 2017. In addition, we surveyed physicians’
awareness regarding the disease to determine whether patients suspected of having Q fever
were being accurately diagnosed and whether confirmed patients were followed up to assess
the status of the disease after primary infection.
Methods
Ethics statement
This study was approved by the Institutional Review Board of Ajou University Hospital. This
was a retrospective study using anonymized, aggregated data from the KCDC and the included
hospitals. Since this study did not have a harmful influence on the patients or the institutions,
the Institutional Review Board waived the requirement for obtaining written consent from the
patients.
Study design and data collection
A retrospective descriptive study was conducted based on the Q fever epidemiological investi-
gation reports, which were submitted to the KCDC from 2011 to 2017. These reports included
data on age, sex, residential area, date of symptom onset, date of diagnosis, and behavioral risk
factors such as contact with animals or occupational exposure to C. burnetii. To collect clinical
information, we reviewed medical records directly from all 26 hospitals that had reported at
least one case of Q fever during the study period. Clinical data on the following were collected
from the 26 hospitals: age, sex, date of symptom onset, date of first hospital visit, underlying
comorbidities, pregnancy status, initial clinical manifestations, laboratory test results, pre-
scribed antibiotics, and treatment outcomes.
Diagnosis of Q fever
Based on the laboratory criteria, acute Q fever was defined as confirmed or probable in
patients with symptoms consistent with acute febrile illness such as flu-like symptoms, hepati-
tis, or pneumonia. Laboratory-confirmed cases of acute Q fever were defined as follows: 1) a
�4-fold increase in immunoglobulin G (IgG) titer to phase II antigen between paired serum
samples or 2) positive polymerase chain reaction (PCR) results for C. burnetii nucleic acid in
the clinical specimens. If the IgG titer to phase II antigen in the acute phase was�1:256 and
the follow-up serum sample from the convalescent phase was not collected, the case was con-
sidered a laboratory probable case. Chronic Q fever was diagnosed based on serological test,
PCR, or culture results in patients with the following clinical presentations: culture-negative
endocarditis, vascular infection, osteomyelitis, osteoarthritis, or chronic organ infection with-
out specific etiology. The serological criteria for the diagnosis of chronic Q fever were a single
IgG titer to phase I antigen�1:800 and a higher antibody titer to phase I antigen than to phase
II antigen.
Serological tests for diagnosing C. burnetii infection were performed at the KCDC using
IFA assay kits (Focus diagnostics, Cypress, CA, USA). Molecular diagnosis was performed
using real-time PCR with the C. burnetii IS1111 gene in individual laboratories.
Survey to evaluate physicians’ awareness regarding Q fever
We administered an online survey to physicians, including infectious disease specialists, who
were registered with the Korean Society of Infectious Disease from December 17 to December
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31, 2018. The survey consisted of questions to investigate physicians’ awareness regarding how
to accurately diagnosis and manage Q fever. The questionnaire contained 12 questions regard-
ing physicians’ clinical careers, place of work, experience in treating patients with Q fever, and
knowledge regarding its diagnosis and management. The detailed questions and their answers
are presented in S1 Appendix.
Data analysis
The epidemiological data provided by the KCDC were used to analyze the spatial and temporal
distribution of Q fever in South Korea. To describe the spatial distribution of disease, we used
the incidence rates expressed as the total number of cases per 100,000 persons at the national
and regional levels. The average number of inhabitants in the regions was obtained from the
data provided by the Korean Statistical Information Service database [8].
Clinical data are expressed as number with percentage for categorical variables and median
with interquartile range (IQR) for continuous variables. To determine the differences between
baseline characteristics of patients with acute and chronic Q fever, Chi-square test was used
for the categorical variables and Mann–Whitney test was used for the continuous variables.
Cases in which the clinical data were unavailable from the hospitals were only included in the
analysis of the spatial and temporal distribution using only the data from the KCDC.
Results
Nationwide incidence of Q fever in South Korea
A total of 241 Q fever cases were reported to the KCDC from 2011 to 2017. The cases occurred
sporadically across the country. The median age of patients with Q fever was 54.5 years (IQR
47.0–62.0 years), with 70 (35.0%), 46 (23.0%), and 37 (18.5%) patients in the 50s, 60s, and 40s
age groups, respectively (S1 Fig). The nationwide incidence rate from 2011 to 2017 was 0.07
cases per 100,000 persons per year. However, there was a sharp increase from 0.02 cases per
100,000 persons per year in 2011 to 0.05–0.19 cases per 100,000 persons per year after 2015.
The highest incidence was observed in Chungbuk (0.53 cases per 100,000 persons per year),
followed by Chungnam (0.27 cases per 100,000 persons per year) (Fig 1). Although Q fever
case were most commonly reported in summer (32.0%) and autumn (30.3%), cases were
reported throughout the year (S1 Table).
Epidemiological characteristics of patients with Q fever
Of the 241 patients reported to the KCDC, 200 (83%) patients whose data were available in the
hospital databases were included in the analysis of the epidemiological characteristics of Q
fever. Table 1 shows a comparison of the baseline characteristics of patients with acute and
chronic Q fever in South Korea. The median age of patients with acute Q fever was 54.0 years
(IQR 46.0–62.0 years), and there were 165 (90.2%) male patients. Among the 183 patients with
acute Q fever, 45 (24.6%) patients had occupational risks. In addition, 43 (23.5%) patients had
a history of animal contact (of any kind). Although the most common kinds of animal contact
were domestic ruminants such as goats (21 cases, 11.5%) and cattle (13 cases, 17.1%), some
patients had a history of contact with a wide range of companion animals and livestock, such
as dogs (3 cases, 1.6%) and pigs (1 case, 0.5%). In total, 85 (46.4%) patients with acute Q fever
lived in rural areas, and they were likely to live near livestock farms. Epidemiological factors
associated with Q fever, such as occupation, history of animal contact, and living area, were
identified in only 88 (48.1%) cases of acute Q fever. There was no statistically significant differ-
ence in the epidemiological characteristics between patients with acute and chronic Q fever
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(P> 0.05). However, patients with chronic Q fever were more likely to have congestive heart
failure (P = 0.001), heart valve insufficiency (P< 0.001), prosthetic heart valves (P = 0.037),
and arterial aneurysms (P< 0.001) than patients with acute Q fever.
Clinical characteristics of patients with acute Q fever
Patients with acute Q fever commonly presented with nonspecific symptoms, including fever
(n = 175, 95.6%), myalgia (n = 107, 58.5%), and chills (n = 101, 55.2%) (Table 2). Initial labora-
tory findings showed modestly elevated levels of C-reactive protein (7.9 mg/dL [IQR 2.6–12.3
mg/dL]) and alanine aminotransferase (74 IU/L [IQR 37–128 IU/L]), with barely normal
ranges of white blood cells (7,920 /mm3 [IQR 5,287–11,202 /mm3]). The clinical manifesta-
tions were primarily hepatitis (118 cases, 64.5%), isolated febrile illness (44 cases, 24.0%), and
Fig 1. Geographic distribution of patients with Q fever in South Korea from 2011 to 2017. Source: https://www.ngii.go.kr/eng/main.do.
https://doi.org/10.1371/journal.pntd.0009467.g001
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pneumonia with or without hepatitis (17 cases, 9.3%). Among the patients with acute Q fever,
116 (63.4%) patients underwent serological tests using paired sera collected at least twice dur-
ing the acute and convalescent phase. Therefore, the remaining 67 (36.6%) cases in which only
a single serological test was performed were classified as probable acute Q fever cases. Fifty
(27.3%) patients with acute Q fever had seroconversion, from seronegative in the acute stage
to seropositive in the convalescent stage. After primary infection, serological follow-ups and
echocardiography were performed in 75 (41.0%) and 113 (61.7%) cases, respectively. Positive
PCR results for C. burnetii were identified in seven cases that showed negative serological
results in the acute stage. Clinical and serological follow-ups at 6 months after primary infec-
tion were only performed in 44 (24.0%) patients with acute Q fever. Appropriate antibiotic
treatment, including doxycycline, trimethoprim-sulfamethoxazole, fluoroquinolone, or
macrolide antibiotics, was administered in 158 (86.3%) cases, and the median duration of anti-
biotic treatment was 14.0 days (IQR 9.8–17.0 days). None of the patients with acute Q fever
progressed to persistent localized infection or died.
Table 1. Baseline characteristics of patients with acute and chronic Q fever in South Korea from 2011 to 2017.
Acute Q fever (n = 183) Chronic Q fever (n = 17) P value
No. (%)
Male 165 (90.2) 15 (88.2) 0.681
Age, years (median, IQR) 54.0 (46.0–62.0) 58.0 (51.5–68.0) 0.643
Occupation 45 (24.6) 3 (17.6) 0.767
Agricultural farmer 25 (13.7) 3 (17.6)
Livestock raiser 17 (9.3) 0 (0)
Veterinarian 2 (1.1) 0 (0)
Slaughterhouse worker 1 (0.5) 0 (0)
Others 138 (75.4) 14 (82.4)
Animal contact 43 (23.5) 3 (17.6) 0.767
Goat 21 (11.5) 0 (0)
Cattle 13 (7.1) 3 (17.6)
Dog 3 (1.6) 0 (0)
Rabbit 2 (1.1) 0 (0)
Deer 1 (0.5) 0 (0)
Hoarse 1 (0.5) 0 (0)
Cat 1 (0.5) 0 (0)
Pig 1 (0.5) 0 (0)
Living area: rural 85 (46.4) 6 (35.3) 0.377
Underlying diseases 69 (37.7) 12 (70.6) 0.008
Hypertension 44 (24.0) 3 (17.6) 0.767
Diabetes mellitus 38 (20.8) 2 (11.8) 0.533
Congestive heart failure 6 (3.3) 5 (29.4) 0.001
Heart valve insufficiency 0 (0) 5 (29.4) <0.001
Heart valve prosthesis 2 (1.1) 2 (11.8) 0.037
Arterial aneurysm 1 (0.5) 6 (35.3) <0.001
Chronic pulmonary disorder 1 (0.5) 0 (0) 1
Malignancy 4 (2.2) 0 (0) 1
Hospitalization 152 (83.1) 13 (76.5) 0.506
Illness onset to hospital visit, (median, IQR) 7 (4–14) 10 (5–16) 0.425
IQR: interquartile range.
https://doi.org/10.1371/journal.pntd.0009467.t001
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Clinical characteristics of patients with chronic Q fever
Of the 200 patients with Q fever enrolled in this study, 17 patients were classified as having
chronic Q fever. Vascular infection (8 cases, 47.1%) was the most frequent manifestation of
chronic Q fever (Table 3). Of these 8 cases, 3 cases had aortic prosthesis-related infections and
the other 5 cases had an infected aortic aneurysm. Six (37.5%) patients had endocarditis. Surgi-
cal treatment, such as valve replacement or vascular prosthesis removal, was performed in 7
Table 2. Clinical characteristics of patients with acute Q fever in South Korea from 2011 to 2017.










WBC (/mm3), median (IQR) 7,920 (5,287–11,202)
Platelet (×103/mm3), median (IQR) 199 (127–371)
CRP (mg/dL), median (IQR) 7.9 (2.6–12.3)
ALT (IU/L), median (IQR) 74 (37–128)
LDH (IU/L), median (IQR) 399 (272–587)
Diagnostic test
Initial seronegative result 50 (27.3)
Positive PCR 7/29 (24.1)
Clinical manifestations
Hepatitis 118 (64.5)
Isolated febrile illness 44 (24.0)






Follow-up after primary infection
Serological test�3 75 (41.0)
Serological test�4 43 (23.5)
Echocardiography 113 (61.7)
6-month follow-up 44 (24.0)
Prognosis
Chronic Q fever after primary infection 0 (0)
Treatment duration (day), median (IQR) 14.0 (9.8–17.0)
IQR, interquartile range; WBC, white blood cell; CRP, C-reactive protein; ALT, alanine aminotransferase; LDH,
lactate dehydrogenase.
�Confirmed or probable cases were classified using the laboratory criteria with clinical evidence of C. burnetii
infection.
https://doi.org/10.1371/journal.pntd.0009467.t002
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(41.2%) cases. The median duration of antibiotic treatment was 24.0 months (IQR 13.5–40.0
months) for patients with chronic Q fever. The mortality rate was 23.5%.
Survey to evaluate the physician’s awareness regarding Q fever
We surveyed 1,226 physicians online, including 243 infectious disease specialists, and the
response rate was 8.4%. The questionnaire results are presented in Table 4. Most physicians
(80.6%) worked in university-affiliated hospitals, and 86.4% of respondents had experience
performing Q fever tests. However, 38.7% of respondents had no experience in diagnosing Q
fever, and 35.0% of respondents had only experience of one or two cases of Q fever. When
patients were suspected of having acute Q fever, 55.3% of respondents rarely conducted a sec-
ond serological test in the convalescent stage if the sera from the acute stage was negative.
With regard follow-up clinical assessments and serological tests repeated over 6 months to
identify cases of chronic Q fever after acute Q fever, 40.8% of respondents stated that clinical
assessments and serological tests were not repeated after primary infection, while 22.3% of
respondents repeated clinical assessments and serological tests. The other questions and their
results are presented in S2 Table.
Discussion
This study shows that Q fever is becoming an endemic disease in the midwestern area of South
Korea. Although the incidence rate of Q fever was as low as 0.07 cases per 100,000 persons per
year across the county, the annual incidence rate has risen sharply, reaching up to 0.19 cases
per 100,000 persons in 2017. Additionally, some areas such as Chungbuk (0.53 cases per
Table 3. Clinical characteristics of patients with chronic Q fever in South Korea from 2011 to 2017.









WBC (/mm3), median (IQR) 8,380 (5,703–12,570)
Platelet (×103/mm3), median (IQR) 235 (129–331)
CRP (mg/dL), median (IQR) 7.4 (3.5–10.0)
ALT (IU/L), median (IQR) 56 (25–160)
LDH (IU/L), median (IQR) 402 (259–489)
Clinical manifestations
Vascular infection 8 (47.1)
Endocarditis 6 (35.3)
Bone and joint infection 3 (17.6)
Prognosis
Surgical treatment 7 (41.2)
Treatment duration (month), median (IQR) 24.0 (13.5–40.0)
IQR, interquartile range; WBC, white blood cell; CRP, C-reactive protein; ALT, alanine aminotransferase; LDH,
lactate dehydrogenase.
https://doi.org/10.1371/journal.pntd.0009467.t003
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100,000 persons per year) and Chungnam (0.27 cases per 100,000 persons per year) showed a
much higher incidence than the other areas. Although C. burnetii is widely distributed world-
wide, except in New Zealand, human Q fever has been reported primarily in endemic areas
such as Australia, France, and Germany [9,10]. Its annual incidence was 1.7–4.0 cases per
Table 4. Physician’s awareness regarding the diagnosis and management of Q fever.
Questions and answers Response rate
(%)
Q1) Have you ever requested a Q fever antibody or PCR test? How many patients did you test for
Q fever?




Q2) For which patients did you request a Q fever test? (select all applicable items)
Never requested a Q fever test 11.7
A febrile patient with an occupational risk, such as livestock raisers 40.8
A febrile patient with a history of animal contact, such as contact with cattle, sheep, or goats 45.6
A febrile patient with a history of visiting a barn or farm 31.1
A patient who has fever of unknown origin >3 weeks without any epidemiological risk 60.2
A patient who has unexplained fever within 2 weeks 46.6
A patient with fever and modestly elevated transaminase levels (AST/ALT <200 IU/L) 31.1
A patient with atypical pneumonia 9.7
A patient with culture-negative endocarditis 42.7
Q3) How many patients have you diagnosed with Q fever?
None at all 38.7
1–2 patients have been diagnosed with Q fever 35.0
3–5 patients have been diagnosed with Q fever 17.5
6–10 patients have been diagnosed with Q fever 3.9
>10 patients have been diagnosed with Q fever 4.9
Q4) If a patient who was suspected to have acute Q fever had a negative result in their first
serological test, did you perform a follow-up serological test at the convalescent stage of the
illness?
Follow-up serological tests were rarely performed 55.3
A second serological test was performed if possible 37.8
A patient was strongly recommended to undergo a second serological test for Q fever 6.9
Q5) Why was a second serological test for Q fever not performed in suspected patients with Q
fever who had initially negative serological result at the acute stage of illness? (select all applicable
items)
They were diagnosed with other diseases 53.4
Unable to follow-up the patient after clinical improvement 53.4
The need for a follow-up test to identify Q fever was considered low after symptom improvement 52.4
Q6) Do you repeat the clinical assessments and serological tests over 6 months to identify
chronic Q fever after acute Q fever was diagnosed?
No, clinical assessments and serological tests are not repeated 40.8
Yes, clinical assessments and serological tests are repeated once or twice 36.9
Yes, clinical assessments and serological tests are repeated for at least 6 months 22.3
Q7) Have you ever performed the serological test or the PCR test for Q fever in patients with
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100,000 persons in Australia and 0.1–0.4 cases per 100,000 persons in France, Germany, and
Bulgaria [11–13]. The Netherlands experienced a large-scale outbreak of Q fever with>4,000
cases between 2007 and 2010; prior to the outbreak, approximately 10–30 cases were reported
annually [2]. The outbreak of Q fever in the Netherlands was strongly associated with dairy
goat farms [14]. Although there is no clear explanation for the recent trend toward an increase
in the number of cases in South Korea, this finding could be explained by two assumptions.
First, if more diagnostic tests are performed because of increased disease awareness among the
medical staff, more Q fever diagnoses can be expected. Second, the increased incidence in
humans might also be associated with an increase in Q fever in animals. The number of Q
fever serological tests that were requested by the KCDC increased by 5.1-fold between 2014
and 2017 [15]. Through our online survey, we can also verify that most physicians were fully
aware of which patients needed to be tested for Q fever. However, increasing testing may not
be the only reason for the increase in human Q fever cases in South Korea. Although the num-
ber of animals with Q fever in livestock farms was low, with<10 cases reported each year, this
number has been increasing steadily since animal Q fever was first reported in 2013. In addi-
tion, the number of goat farms increased by 1.4-fold from 2012 to 2017, and there was a strong
correlation between the number of goat farms and the incidence of human Q fever [15].
Although animal sources have not been identified in most Q fever cases, previous studies have
suggested that epizootic Q fever in goat herds is associated with outbreaks in humans [16,17].
This study revealed that in South Korea, Q fever more commonly occurred in men in their
50s without any epidemiological risk factors. Although human Q fever is a zoonotic disease, most
patients with Q fever did not have an occupational risk (24.0%) or a history of animal contact
(23.0%), which increases the risk of exposure to C. burnetii. Given that the main route of transmis-
sion of Q fever is aerosol-type propagation through dust or wind, human Q fever cases can occur
sporadically without direct occupational or animal exposure [3,10]. This result is similar to that
reported by a French study, demonstrating that only 8% of acute Q fever cases were related to
occupational risks and 35.4% cases were related to animal contact [18]. These epidemiological
characteristics in patients with Q fever may have led to an underdiagnosis of acute Q fever.
The clinical manifestations in patients with acute Q fever are different in each country [18–
21]. Hepatitis was the most common clinical manifestation of acute Q fever in South Korea.
Although there is no obvious hypothesis to explain why most patients with acute Q fever pre-
sented with hepatitis in South Korea, a possible explanation can be the significant correlation
observed in this study between the number of goat farms and the incidence in human Q fever
in South Korea. It is known that hepatitis is more frequent clinical manifestation in sheep- and
goat-breeding areas [22]. Although animal sources were not identified in most Q fever cases,
the most common kind of animal contact was goats in this study, and there was an increase in
the number of goat farms during the study period.
Among the patients with acute Q fever, seroconversion was identified in 27.3% patients
through collection of sera at least twice during the acute and convalescent stage; 36.6% patients
did not undergo a second serological test during the convalescent stage. Because seroconver-
sion usually occurs 7–15 days after onset of symptoms in acute Q fever, it is necessary to fol-
low-up patients with an antibody test using convalescent serum samples taken 3–6 weeks apart
[23]. However, as shown in the results of our survey, more than half of the physicians did not
follow-up patients using a serological test. PCR tests can be helpful in the diagnosis of acute Q
fever in patients who developed symptoms within 2 weeks; the sensitivity of PCR tests has
been reported to be 24%–98% [23]. This study also showed that PCR tests were useful for diag-
nosing acute Q fever in patients who had negative serological results at the acute stage.
Although PCR testing for C. burnetii is not widely used to diagnose Q fever in South Korea, its
use will enable clinicians to make a correct and early diagnosis of acute Q fever.
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In South Korea, vascular infection was a more common clinical manifestation than endo-
carditis in patients with chronic Q fever. It was known that endocarditis is most common
manifestation among patients with chronic Q fever. In some studies, C. burnetii infection was
the most frequently identified etiology in patients with culture-negative endocarditis [24,25].
In this study, Q fever endocarditis was only confirmed in 6 cases. However, culture-negative
endocarditis cases accounted for about a quarter of endocarditis cases in South Korea [26,27].
This suggests that Q fever endocarditis may be an underestimated disease in South Korea, and
serological tests or PCR tests for C. burnetii should be more actively performed in cases of cul-
ture-negative endocarditis. This study revealed that patients with chronic Q fever were likely
to undergo surgery (41.2%), such as valve replacement or vascular surgery, and that they had a
high mortality (23.5%). These clinical burdens and features of chronic Q fever are well-known
in France and the Netherlands [28,29]. In South Korea, arterial aneurysms, heart valve insuffi-
ciency, and prosthetic valves were also risk factors in patients with chronic Q fever. Although
there were only a few identifiable cases of chronic Q fever, the study results suggest that it is
important to screen patients with risk factors, follow-up patients using serological tests, and
appropriately monitor clinical changes in patients with acute Q fever. A study reported that
the risk of endocarditis reached 39% among patients with acute Q fever and heart valve disease
[30]. Many experts recommend serological and clinical follow-ups for at least 6 months up to 2
years after acute Q fever, depending on the risk factors [3,23]. Some experts recommended
that patients with acute Q fever and risk factors for chronic Q fever should receive prophylactic
antibiotics for 1 year [23]. However, our results showed that a follow-up for 6 months to iden-
tify chronic Q fever was only performed by 24.0% of physicians and that only 41.0% of physi-
cians performed >3 follow-up serological tests. Hence, chronic Q fever, despite its clinical
severity, seems to be an underreported and neglected infectious disease.
The results of the survey on physician’s awareness indicated that many physicians, includ-
ing infectious disease specialists, did not know how to correctly diagnose and manage Q fever.
This may be due to the nonspecific clinical features of Q fever and the limited diagnostic tools
available. Q fever can lead to persistent localized infection in certain patients with risk factors,
therefore, it is necessary for clinicians to increase their awareness regarding Q fever to enable
correct diagnosis and management.
In conclusion, Q fever is becoming an endemic disease in the midwestern areas of South
Korea, such as Chungbuk and Chungnam, and is mainly diagnosed in previously healthy men
in their 50s living in rural areas without other epidemiological risk factors. C. burnetii infection
can occur in susceptible persons living far from infected animals or contaminated environ-
ments because aerosol particles can travel with wind for miles. Therefore, clinicians should
suspect Q fever in patients with acute hepatitis of unknown etiology in South Korea. In addi-
tion, given the upward trend of acute Q fever cases and the clinical severity of chronic Q fever,
appropriate diagnostic and management practices should be followed after primary C. burnetii
infection. The disease burden of chronic Q fever should be evaluated in patients with culture-
negative endocarditis or infected aneurysms.
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vakia. Emerg Infect Dis. 1999; 5: 388–394. https://doi.org/10.3201/eid0503.990309 PMID: 10341175
18. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, et al. Q fever 1985–1998.
Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000; 79: 109–123.
https://doi.org/10.1097/00005792-200003000-00005 PMID: 10771709
19. Domingo P, Munoz C, Franquet T, Gurgui M, Sancho F, Vazquez G. Acute Q fever in adult patients:
report on 63 sporadic cases in an urban area. Clin Infect Dis. 1999; 29: 874–879. https://doi.org/10.
1086/520452 PMID: 10589906
20. Alende-Castro V, Macia-Rodriguez C, Novo-Veleiro I, Garcia-Fernandez X, Trevino-Castellano M,
Rodriguez-Fernandez S, et al. Q fever in Spain: Description of a new series, and systematic review.
PLoS Negl Trop Dis. 2018; 12: e0006338. https://doi.org/10.1371/journal.pntd.0006338 PMID:
29543806
21. Wielders CC, Wuister AM, de Visser VL, de Jager-Leclercq MG, Groot CA, Dijkstra F, et al. Characteris-
tics of hospitalized acute Q fever patients during a large epidemic, The Netherlands. PLoS One. 2014;
9: e91764. https://doi.org/10.1371/journal.pone.0091764 PMID: 24614585
22. Hartzell JD, Marrie TJ, Raoult D. Coxiella burnetii (Q Fever). In: Bennett JE, Dolin R, Blaser MJ, ed.
Principles and practice of infectious diseases. 9th ed. Churchill Livingstone, Philadelphia, Pa, pp
2360–2367.
PLOS NEGLECTED TROPICAL DISEASES An increase of Q fever in South Korea
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009467 June 2, 2021 13 / 14
23. Eldin C, Melenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q Fever to Coxiella
burnetii Infection: a Paradigm Change. Clin Microbiol Rev. 2017; 30: 115–190. https://doi.org/10.1128/
CMR.00045-16 PMID: 27856520
24. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, et al. Infective endocarditis in
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